Consensus EPS · Q2 2026
-$0.77
Consensus revenue · Q2 2026
$0
Analysts
5
Expected report
Aug 12, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 5 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| EPS | -$0.96 | -$0.77 | -$0.57 |
| EBITDA | $0 | $0 | $0 |
| EBIT | $0 | $0 | $0 |
| Net income | -$27.6M | -$24.2M | -$19.4M |
- Revenue$0
- EPS-$0.77
- EBITDA$0
- EBIT$0
- Net income-$24.2M
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
| Metric | Now | 30d ago | 60d ago | 90d ago | 30d Δ |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — |
| EPS | -$0.73 | -$0.72 | — | — | -2.3% |
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Alto Neuroscience (ANRO) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
- Low
- $24.00
- Consensus
- $34.60
- Median
- $35.00
- High
- $50.00
- Current
- $27.07
- Upside
- +27.8%
Upside calculated vs most recent trading price of $27.07.
Consensus across all covering analysts. See the ranking ›
Analyst ratings
Consensus: Buy — based on 9 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 18, 2026 | Baird | maintain | Outperform | Outperform |
| May 14, 2026 | Wedbush | maintain | Neutral | Neutral |
| May 11, 2026 | HC Wainwright& Co. | maintain | Buy | Buy |
| May 11, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Apr 22, 2026 | Chardan Capital | maintain | Buy | Buy |
| Apr 2, 2026 | Wedbush | maintain | Neutral | Neutral |
| Apr 2, 2026 | Jones Trading | maintain | Buy | Buy |
| Apr 2, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Apr 2, 2026 | Chardan Capital | maintain | Buy | Buy |
| Apr 2, 2026 | Baird | maintain | Outperform | Outperform |
- May 18, 2026BairdOutperform
- May 14, 2026WedbushNeutral
- May 11, 2026HC Wainwright& Co.Buy
- May 11, 2026HC Wainwright & Co.Buy
- Apr 22, 2026Chardan CapitalBuy
- Apr 2, 2026WedbushNeutral
- Apr 2, 2026Jones TradingBuy
- Apr 2, 2026HC Wainwright & Co.Buy
- Apr 2, 2026Chardan CapitalBuy
- Apr 2, 2026BairdOutperform
Frequently asked questions
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.